These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 6811660)

  • 1. Measurement of antibodies to meningococcal group B polysaccharide: low avidity binding and equilibrium binding constants.
    Mandrell RE; Zollinger WD
    J Immunol; 1982 Nov; 129(5):2172-8. PubMed ID: 6811660
    [No Abstract]   [Full Text] [Related]  

  • 2. Avidity of the immunoglobulin G response to a Neisseria meningitidis group C polysaccharide conjugate vaccine as measured by inhibition and chaotropic enzyme-linked immunosorbent assays.
    Harris SL; Tsao H; Ashton L; Goldblatt D; Fernsten P
    Clin Vaccine Immunol; 2007 Apr; 14(4):397-403. PubMed ID: 17287312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bactericidal monoclonal antibodies that define unique meningococcal B polysaccharide epitopes that do not cross-react with human polysialic acid.
    Granoff DM; Bartoloni A; Ricci S; Gallo E; Rosa D; Ravenscroft N; Guarnieri V; Seid RC; Shan A; Usinger WR; Tan S; McHugh YE; Moe GR
    J Immunol; 1998 May; 160(10):5028-36. PubMed ID: 9590252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunological properties of monoclonal antibodies specific for meningococcal polysaccharides: the protective capacity of IgM antibodies specific for polysaccharide group B.
    Moreno C; Hewitt J; Hastings K; Brown D
    J Gen Microbiol; 1983 Aug; 129(8):2451-6. PubMed ID: 6415230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production of low-avidity antibody by infants after infection with serogroup B meningococci.
    Pollard AJ; Levin M
    Lancet; 2000 Dec; 356(9247):2065-6. PubMed ID: 11145494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enzyme-linked immunosorbent assay for determination of human antibodies to group C meningococcal polysaccharide.
    Basta MT; Russell H; Guirguis NI; Hafez K; El Kholy A
    Proc Soc Exp Biol Med; 1982 Jan; 169(1):7-11. PubMed ID: 6801668
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of radioimmunoassay and enzyme-linked immunosorbent assay in measurement of antibodies to Neisseria meningitidis group A capsular polysaccharide.
    Beuvery EC; Kayhty MH; Leussink AB; Kanhai V
    J Clin Microbiol; 1984 Oct; 20(4):672-6. PubMed ID: 6436314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of the ontogeny of the murine humoral response to Neisseria meningitidis B capsular polysaccharide reveals levels of complexity relevant to vaccine development.
    Colino J; Outschoorn I
    J Infect Dis; 2001 Dec; 184(12):1538-47. PubMed ID: 11740729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Survey on efficacy of inoculating purified polysaccharide vaccines as an emergency measure in preventing epidemic meningitis].
    Xu CH
    Zhonghua Liu Xing Bing Xue Za Zhi; 1982 Dec; 3(6):328-30. PubMed ID: 6821030
    [No Abstract]   [Full Text] [Related]  

  • 10. A radioactive antigen-binding assay for Neisseria meningitidis polysaccharide antibody.
    Brandt BL; Wyle FA; Artenstein MS
    J Immunol; 1972 Apr; 108(4):913-20. PubMed ID: 4623401
    [No Abstract]   [Full Text] [Related]  

  • 11. Antibodies to meningococcus polysaccharides in nonspecific gamma-globulins from different regions of the world.
    Demina AA; Samsonova IM; Fayet MT; Béranger J; Gibilin N; Plan R; Triau R
    J Hyg Epidemiol Microbiol Immunol; 1983; 27(4):437-44. PubMed ID: 6198376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity and cross-reactivity of antibodies induced in mice by immunization with a group B meningococcal conjugate.
    Coquillat D; Bruge J; Danve B; Latour M; Hurpin C; Schulz D; Durbec P; Rougon G
    Infect Immun; 2001 Nov; 69(11):7130-9. PubMed ID: 11598089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response to antigenic determinants of Neisseria meningitidis lipopolysaccharide investigated with a new radioactive antigen-binding assay.
    Bertram MA; Griffiss JM; Broud DD
    J Immunol; 1976 Mar; 116(3):842-6. PubMed ID: 56401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of the methods of classifying immunoglobulins against group-specific meningococcal polysaccharides].
    Tumanian AA
    Lab Delo; 1986; (8):490-2. PubMed ID: 2429057
    [No Abstract]   [Full Text] [Related]  

  • 15. Two different methods result in the selection of peptides that induce a protective antibody response to Neisseria meningitidis serogroup C.
    Prinz DM; Smithson SL; Westerink MA
    J Immunol Methods; 2004 Feb; 285(1):1-14. PubMed ID: 14871530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of aluminium hydroxide and meningococcal serogroup C capsular polysaccharide on the immunogenicity and reactogenicity of a group B Neisseria meningitidis outer membrane vesicle vaccine.
    Rosenqvist E; Høiby EA; Bjune G; Aase A; Halstensen A; Lehmann AK; Paulssen J; Holst J; Michaelsen TE; Nøkleby H; Frøholm LO; Closs O
    Dev Biol Stand; 1998; 92():323-33. PubMed ID: 9554288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Application of SP-RIA in the antibody surveillance and serologic diagnosis of epidemic cerebrospinal meningitis].
    Chen X
    Zhonghua Liu Xing Bing Xue Za Zhi; 1993 Dec; 14(6):366-70. PubMed ID: 8156584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of the level of antibodies to purified meningococcal antigens].
    Kuznetsova EM; Borisenko IuV; Tsvetkova NV
    Zh Mikrobiol Epidemiol Immunobiol; 1988 Jan; (1):65-8. PubMed ID: 3129887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant can improve protection induced by OMV vaccine against Neisseria meningitidis serogroups B/C in neonatal mice.
    Fukasawa LO; Dias WO; Schenkman RP; Raw I; Tanizaki MM
    FEMS Immunol Med Microbiol; 2004 Jul; 41(3):205-10. PubMed ID: 15196569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meningococcal C polysaccharide vaccine induces immunologic hyporesponsiveness in adults that is overcome by meningococcal C conjugate vaccine.
    Richmond P; Kaczmarski E; Borrow R; Findlow J; Clark S; McCann R; Hill J; Barker M; Miller E
    J Infect Dis; 2000 Feb; 181(2):761-4. PubMed ID: 10669372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.